Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

487.21 +7.02 (+1.46%)
Streaming Delayed Price Updated: 11:48 AM EDT, Apr 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 55,386
Open 480.30
Bid (Size) 486.32 (80)
Ask (Size) 488.10 (120)
Prev. Close 480.19
Today's Range 480.30 - 490.24
52wk Range 250.05 - 628.92
Shares Outstanding 30,998,636
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Big Reasons MEDP Should Be On Your Watchlist
Over the past six months, Medpace’s shares (currently trading at $483.21) have posted a disappointing 11.2% loss while the S&P 500 was down 5.5%. This might ... 
Via StockStory
Topics Stocks
Medpace Holdings Inc (NASDAQ:MEDP) Passes Key CAN SLIM Filters Amid Market Caution ↗
Via Chartmill

Performance

YTD
-14.7%
-14.7%
1 Month
+6.5%
+6.5%
3 Month
-14.4%
-14.4%
6 Month
-5.2%
-5.2%
1 Year
+59.9%
+59.9%

More News

Read More
News headline image
Medpace Holdings, Inc. to Report First Quarter 2026 Financial Results on April 22, 2026
From Medpace Holdings, Inc.
Via Business Wire
News headline image
Q4 Earnings Highs And Lows: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks
Via StockStory
Medpace Holdings Inc (NASDAQ:MEDP) Passes Key CAN SLIM Growth Filter Amid Technical Caution ↗
Via Chartmill
Medpace Holdings Inc (NASDAQ:MEDP) Stock Falls Despite Strong Q4 Earnings Beat ↗
Via Chartmill
News headline image
2 Healthcare Stocks with Exciting Potential and 1 We Avoid
Via StockStory
News headline image
3 Profitable Stocks for Long-Term Investors
Via StockStory
News headline image
Medpace (NASDAQ:MEDP): Strongest Q4 Results from the Drug Development Inputs & Services Group
Via StockStory
News headline image
Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know
Via StockStory
Topics Government World Trade
News headline image
Investment Manager Bets Big on Varonis Stock, According to Recent SEC Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
American Capital Management Doubles Down on Novanta Stock, According to Latest SEC Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Investment Manager Bets on Proto Labs Stock, According to Recent SEC Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
MEDPACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Medpace Holdings, Inc. on Behalf of Medpace Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
6 Stock Ideas for the Next 5 Years ↗
Via The Motley Fool
Topics Artificial Intelligence
Why Big Stock Swings Like Medpace's 55% Jump Usually Have Clear Causes--Not Market Madness ↗
Via The Motley Fool
News headline image
The 5 Most Interesting Analyst Questions From Medpace’s Q4 Earnings Call
Via StockStory
Topics Earnings
News headline image
The Clinical Crisis: A Deep-Dive Into ICON plc (ICLR) Amidst a Transformational Storm
Via Finterra
Topics Artificial Intelligence Fraud Lawsuit
News headline image
1 Cash-Producing Stock with Competitive Advantages and 2 That Underwhelm
Via StockStory
News headline image
MEDP Q4 Deep Dive: Cancellations and Metabolic Trial Mix Pressure Margins Despite Strong Growth
Via StockStory
Topics Artificial Intelligence
News headline image
Medpace (MEDP) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
Medpace (NASDAQ:MEDP) Reports Bullish Q4 CY2025
Via StockStory
News headline image
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Results
From Medpace Holdings, Inc.
Via Business Wire
News headline image
Earnings To Watch: Medpace (MEDP) Reports Q4 Results Tomorrow
Via StockStory
Topics Artificial Intelligence
News headline image
3 Market-Beating Stocks to Consider Right Now
Via StockStory

Frequently Asked Questions

Is Medpace Holdings, Inc. - Common Stock publicly traded?
Yes, Medpace Holdings, Inc. - Common Stock is publicly traded.
What exchange does Medpace Holdings, Inc. - Common Stock trade on?
Medpace Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Medpace Holdings, Inc. - Common Stock?
The ticker symbol for Medpace Holdings, Inc. - Common Stock is MEDP on the Nasdaq Stock Market
What is the current price of Medpace Holdings, Inc. - Common Stock?
The current price of Medpace Holdings, Inc. - Common Stock is 487.21
When was Medpace Holdings, Inc. - Common Stock last traded?
The last trade of Medpace Holdings, Inc. - Common Stock was at 04/01/26 11:48 AM ET
What is the market capitalization of Medpace Holdings, Inc. - Common Stock?
The market capitalization of Medpace Holdings, Inc. - Common Stock is 15.10B
How many shares of Medpace Holdings, Inc. - Common Stock are outstanding?
Medpace Holdings, Inc. - Common Stock has 15B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.